| Obesity drug beats others in phase II trial: lowest dose of tesofensine produced weight loss similar to that of sibutramine and rimonabant.(ACROSS SPECIALTIES): ... An article from: Clinical Psychiatry News | Digitalby Miriam E. Tucker (Author)
| List Price: | $9.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | International Medical News Group | | Page Count: | 3 Pages | | Publication Date: | July 01, 2009 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on July 1, 2009. The length of the article is 874 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Obesity drug beats others in phase II trial: lowest dose of tesofensine produced weight loss similar to that of sibutramine and rimonabant.(ACROSS SPECIALTIES)Author: Miriam E. TuckerPublication: Clinical Psychiatry News (Magazine/Journal)Date: July 1, 2009Publisher: International Medical News GroupVolume: 37 Issue: 7 Page: 27(1)Distributed by Gale, a part of Cengage Learning |
|
